Avert Pharma Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2010.
2010 Delhi, Delhi, India Active
Last Updated:
Access Report
About Avert Pharma Private Limited

Avert Pharma Private Limited, a active private limited company, was established on 10 March 2010 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U36101DL2010PTC199918. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Satish Chand (Director), Satendra Singh (Director). Its latest AGM occurred on 28 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-15 Phase-10,Shiv Vihar, Karawal Nagar,Delhi 110094, Delhi, Delhi, 110094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36101DL2010PTC199918

  • Registration Number

    199918

  • Incorporation Date

    10 March 2010

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 15 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 3.30%
  • Profit Growth **** -2.15%
  • Ebitda **** 1375.23%
  • Net Worth 7.18%
  • Total Assets -16.06%
Company report

Avert Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avert Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Avert Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Satish Chand Director 10 Mar 2010 Current
Satendra Singh Director 10 Mar 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avert Pharma.

Avert Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.3% increase. The company also saw a slight decrease in profitability, with a 2.15% decrease in profit. The company's net worth moved up by a moderate rise of 7.18%.

Avert Pharma revenue growth over time
Avert Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.30%
*******
*******
*******
*******
Revenue from Operations
*******
 3.30%
*******
*******
*******
*******
Total Assets
*******
 -16.06%
*******
*******
*******
*******
Profit or Loss
*******
 -2.15%
*******
*******
*******
*******
Net Worth
*******
 7.18%
*******
*******
*******
*******
EBITDA
*******
 1375.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avert Pharma?

Unlock access to Avert Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Avert Pharma?

Unlock and access historical data on people associated with Avert Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avert Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avert Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avert Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Avert Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Avert Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Satish Chand was appointed as a Director was appointed as a Director on 10 Mar 2010 & has been associated with this company since 15 years 11 months . was completed.

  • Director Appointment

    Satendra Singh was appointed as a Director was appointed as a Director on 10 Mar 2010 & has been associated with this company since 15 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Avert Pharma Private Limited was registered on 10 Mar 2010 with Roc Delhi & aged 15 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avert Pharma Private Limited?

The CIN of Avert Pharma Private Limited is U36101DL2010PTC199918.

Where is Avert Pharma Private Limited headquartered?

Avert Pharma Private Limited is headquartered at A-15 Phase-10,Shiv Vihar, Karawal Nagar,Delhi 110094, Delhi, Delhi, 110094.

When was Avert Pharma Private Limited incorporated?

Avert Pharma Private Limited was incorporated on 10 March 2010.

Who are the current directors of Avert Pharma Private Limited?

The current directors of Avert Pharma Private Limited are

What is the primary industry of Avert Pharma Private Limited?

The primary industry of Avert Pharma Private Limited is Trade.

Is Avert Pharma Private Limited a listed company?

Avert Pharma Private Limited is unlisted.

What is the capital structure of Avert Pharma Private Limited?

The authorized capital of Avert Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Avert Pharma Private Limited?

The compliance status of Avert Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available